CLINICAL CORNER: New-Gen Bariatric Devices Show Promise With Positive Data
This article was originally published in Clinica
Executive Summary
Bariatric medicine for managing obesity and type 2 diabetes has advanced beyond surgical gastric bypass and gastric banding. The annual Digestive Disease Week (DDW) meeting in May highlighted a move towards novel minimally invasive technologies that do not require incisions, and others that do not even require endoscopic placement of the device. Highlights of the meeting include the clinical trial results from three promising technologies: GI Windows' Incisionless Anastomosis System, Allurion Technologies' Elipse Gastric Balloon, and Obalon Therapeutics' Obalon Gastric Balloon System